ExLibris header image
SFX Logo
Title: Statin-induced mevalonate pathway inhibition attenuates the growth of mesenchymal-like cancer cells that lack functional E-cadherin mediated cell cohesion
Source:

Scientific Reports [2045-2322] yr:2014


Collapse list of basic services Basic
Full text
Full text available via PubMed Central
GO
Full text available via PubMed Central Open Access
GO
Document delivery
Request document via Library/Bibliothek GO
Users interested in this article also expressed an interest in the following:
1. Kato, H. "Metformin inhibits the proliferation of human prostate cancer PC-3 cells via the downregulation of insulin-like growth factor 1 receptor." Biochemical and biophysical research communications 461.1 (2015): 115-21. Link to SFX for this item
2. Fliedner, Stephanie M. J. M. "Anti-Cancer Potential of MAPK Pathway Inhibition in Paragangliomas–Effect of Different Statins on Mouse Pheochromocytoma Cells." PLoS ONE 9.5 (2014): -6203. Link to Full Text for this item Link to SFX for this item
3. Kruszelnicka, O. "Differential associations of circulating asymmetric dimethylarginine and cell adhesion molecules with metformin use in patients with type 2 diabetes mellitus and stable coronary artery disease." Amino acids 47.9 (2015): 1951-1959. Link to SFX for this item
4. "Serum apelin and ADMA levels in type 2 diabetics with and without vascular complications." Diabetes & metabolic syndrome : clinical research & reviews. 10.2 Suppl 1. Link to SFX for this item
5. Fu, L. "Leucine amplifies the effects of metformin on insulin sensitivity and glycemic control in diet-induced obese mice." Metabolism, clinical and experimental 64.7 (2015): 845-. Link to SFX for this item
6. Lee, I. "Statins, 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors, potentiate the anti-angiogenic effects of bevacizumab by suppressing angiopoietin2, BiP, and Hsp90alpha in human colorectal cancer." British Journal of Cancer 111.3 (2014): 497-505. Link to Full Text for this item Link to SFX for this item
7. Kritharides, L. "Associations between the use of metformin, sulphonylureas, or diet alone and cardiovascular outcomes in 6005 patients with type 2 diabetes in the FIELD study." Diabetes research and clinical practice 94.2: 284-290. Link to SFX for this item
8. Fidan, E. "The effects of rosiglitazone and metformin on inflammation and endothelial dysfunction in patients with type 2 diabetes mellitus." Acta Diabetologica 48.4 (2011): 1-6. Link to SFX for this item
Select All Clear All

Expand list of advanced services Advanced
A service provided by the Library of the Wissenschaftspark Albert Einstein, Potsdam, Germany.
© 2005 SFX by Ex Libris Inc.